Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$1.28 +0.16 (+14.29%)
At close: Aug 20, 2026 · 4:00 PM EDT

Creative Medical Technology Holdings (CELZ) Tax Rate (2018 - 2025)

Creative Medical Technology Holdings (CELZ) posted quarterly Tax Rate of 18.14% for Q4 2025, up 4242.0% year-over-year from 0.42% in Q4 2024, and up 70.05% quarter-over-quarter from 60.56% in Q4 2024.

Creative Medical Technology Holdings (CELZ) Tax Rate (2018 - 2025) Analysis & Trends

Creative Medical Technology Holdings (CELZ) has reported Tax Rate for 4 consecutive years, with 18.14% the latest figure, recorded in Q4 2025.

  • In Q4 2025, Tax Rate rose 4242.0% year-over-year to 18.14%; the TTM figure through Mar 2026 stood at 5.94% (up 1249.0% YoY), while the FY2025 annual figure was 5.71%, up 1473.0% from the prior year.
  • Tax Rate rose to 18.14% in Q4 2025 per CELZ's latest filing, from 60.56% in the prior quarter.
  • Across five years, Tax Rate topped out at 18.14% in Q4 2025 and bottomed at 60.56% in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 20.98%
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 15.11%
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 10.91%
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn -1.96%
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 24.15%
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 7.49%
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn -16.71%
8 Royalty Pharma 26.98 Bn 26.14 Bn - -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 34.12%
10 Creative Medical Technology Holdings 1.83 Mn 1.83 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 -18.14%
Dec 31, 2025 -18.14%
Dec 31, 2025 -18.14%
Dec 31, 2024 -60.56%
Dec 31, 2024 -60.56%
Dec 31, 2024 -60.56%
Dec 31, 2020 -0.18%
Dec 31, 2020 -0.18%
Dec 31, 2020 -0.18%
Dec 31, 2018 -12.13%
Dec 31, 2018 -12.13%
Dec 31, 2018 -12.13%